American Pharmacogenomics Association (APGxA)
The American Pharmacogenomics Association (APGxA) provides an exclusive platform for PGx leaders to connect, collaborate, and leverage the commercial opportunities within this rapidly evolving field. APGxA members gain access to invaluable resources, insights, and networking opportunities that drive business growth and success. Join APGxA and position your organization at the forefront of personalized medicine.
Sign up for our Community Pop-Up PGx Screening!
Get the Right Meds for YOU: A Year-Long Ten City Tour of DNA Medication Screening
The American Pharmacogenomics Association (APGxA) is a driving force in the burgeoning field of pharmacogenomics, bridging the gap between genetic insights and practical healthcare solutions. APGxA serves as a central hub for industry professionals, fostering collaboration, education, and research to accelerate the integration of pharmacogenomics into mainstream clinical practice.
Beyond its core activities, APGxA actively engages in public outreach and advocacy, partnering with key stakeholders to champion the adoption of pharmacogenomic testing. By equipping healthcare providers and patients with the knowledge and tools to interpret genetic data, APGxA empowers informed decision-making and paves the way for personalized treatment plans.
With its additional International division, APGxA extends its reach globally, promoting awareness and facilitating the adoption of pharmacogenomics worldwide. Through its multifaceted efforts, APGxA is catalyzing the transformation of healthcare, enabling more personalized, effective, and safer drug therapies tailored to each patient’s unique genetic profile.
What we have to offer…
Membership Benefits
ADVOCACY, not mentioned to the list on the right because there is simply too much to say about it.
The American Pharmacogenomics Association (APGxA) is a catalyst for business growth in the pharmacogenomics sector, providing invaluable support to a wide range of professionals, from labs and pharmacists to researchers and billing specialists. APGxA equips its members with the knowledge, resources, and networking opportunities needed to thrive in this rapidly evolving field. By fostering collaboration, innovation, and education, APGxA is driving the growth of the pharmacogenomics market, creating new business opportunities, and ultimately improving patient care through personalized medicine.
The American Pharmacogenomics Association proudly partners with the Western New England University College of Pharmacy’s Master of Science in Pharmacogenomics program. Taught in the cutting-edge facilities of the Center for the Science and Pharmacy, the curriculum equips students for careers in research, the pharmaceutical sector, regulatory bodies, genetic testing labs, or clinical environments. This program offers a comprehensive foundation for those seeking to advance in the field of pharmacogenomics.
Our Webinar Series. Unmatched.
To Be Announced
Date: TBA
Time: 9:00AM PST
Our 4th quarter webinar is currently being vetted. If you are interested in presenting a webinar on our platform, please reach out.
All members have access to our history of webinars, ebooks and courses. If you are still not a member, please consider joining APGxA.
2026 Summit
Date: TBA
Time: TBA
Join us for the highly anticipated 2026 Summit, where pharmacogenomics business leaders and educators converge as the industry approaches the projected $50 billion milestone. This premier gathering will bring together industry executives and education professionals to explore market opportunities and professional development in personalized medicine. The 2026 Summit promises to be an essential event for advancing pharmacogenomics
… Or Take Our Popular PGx Certificate Course
Pharmacogenomics: Understanding Genetic Influences on Drug Response
This course on Pharmacogenomics delves into the intricate relationship between genetic variations and drug responses, tackling the pressing issue of optimizing medication efficacy and minimizing adverse reactions. Click the button to get more information …
Grab a cup and join us for our popular live monthly PGx Coffee Chat
Next one: August 21, 2025 (off for July) at 7:30am PST (every third Thursday) This one is for APGxA members only.
Our Curated eBook Library
Education will remain one of our primary goals. The American Pharmacogenomics Association (APGxA) prioritizes education as a cornerstone of its mission. By empowering patients and healthcare professionals with knowledge about PGx testing, APGxA strives to bridge the gap between scientific advancements and real-world application. individuals to make informed decisions about their medications, while also equipping healthcare providers with the tools to integrate PGx into personalized treatment plans. Ultimately, APGxA’s educational initiatives pave the way for a future of optimized medication management and improved patient outcomes.
Our Published Content Curated Just for You
Lydia Kariuki has been named Managing Editor of the APGxA popular published business content blog. Her writing history goes deep with the Founder, almost 20 years back. Lydia will be covering recent studies in the space as short-form blogs, and share relevant market news where it makes sense. She will also soon facilitate 30-minute interview with key contributors to the Pharmacogenomics space.
Lydia Kariuki
Managing Editor
Lydia@apgxa.com
legislation
We support Bill H.R. 6875 – 17th Congress (2022)
Sponsored by Representative, Eric Swalwell, this bill sets out requirements and activities to address adverse drug events, including using pharmacogenomic testing to prevent them. (Pharmacogenomic testing uses a patient’s genetic information to help determine the safety, efficacy, and dosage of medications for treatments.)
A proud handful of our member companies…
